Analysts anticipate Lineage Cell Therapeutics to report an earnings per share (EPS) of $-0.03. Anticipation surrounds Lineage ...

Lineage Cell Therapeutics, Inc.’s LCTX share price has dipped by 6.64%, which has investors questioning if this is right time to buy.

This explainer outlines how neurons and glial cells coordinate electrical and chemical signals to form complex brain networks ...

It also offers ReSonance (ANP1), an allogeneic auditory neuron progenitor cell transplant, which is in preclinical development for the treatment of sensorineural hearing loss; and PNC1 ...

Pseudotime trajectory analysis of white matter oligodendrocyte lineage cells was performed ... Importantly, these genetic risks can impact patient life–spans from prenatal development to senescence.

E, Violin plots of the normalised expression of endoderm, mesoderm, neuroectoderm, and oligodendrocyte progenitor markers ... which is part-funded by the European Regional Development Fund (ERDF) via ...

Viral-mediated Oct4 overexpression induces direct conversion of wildtype mammalian Müller glia to bipolar neurons, and this process is synergistically enhanced by loss of Notch signaling.

Like in many companies, the pandemic hastened Pirelli's speed of digital research and development exercises. Pierangelo Misani, Pirelli's chief technical officer and executive vice president ...

In the rapidly evolving landscape of software development, one month can be enough to create a trend that makes big waves. In fact, only two months ago, Andrej Karpathy, a former head of AI at ...